The bill improves consumer safety by empowering enforcement to block and remove falsely marketed or violative supplements, but does so at the cost of imposing compliance burdens that may disrupt small supplement businesses and reduce availability or raise prices for consumers.
Patients with chronic conditions and other consumers are less likely to encounter products falsely marketed as dietary supplements because customs and enforcement can block/seize violative imports and remove misclassified products from U.S. commerce.
Small supplement businesses that used debarred third parties for manufacturing or packing could be disrupted or shut out of interstate markets, threatening livelihoods and local suppliers.
Consumers may face reduced availability or higher prices for some supplement products if imports are detained or domestic producers withdraw items to ensure compliance.
Manufacturers and retailers could face increased compliance costs or lost inventory if products are reclassified and excluded from commerce, raising business costs that may be passed on to consumers or borne by taxpayers.
Based on analysis of 2 sections of legislative text.
Makes it illegal to sell products marketed as dietary supplements that don't meet the legal definition and bars supplements prepared with assistance from debarred persons; allows FDA/CBP to exclude or seize such products.
Introduced February 5, 2026 by Frank Pallone · Last progress February 5, 2026
Bars bringing into interstate commerce any product marketed as a dietary supplement that does not meet the legal definition of a “dietary supplement,” and bars dietary supplements that were prepared, packed, or held with the assistance of (or at the direction of) a person who has been debarred under federal law. It also makes those products subject to existing import-exclusion and seizure authorities so FDA/Customs can block or seize violative shipments at the border or in commerce. The change tightens enforcement tools against misbranded or illicitly produced supplements and extends penalties to products connected to debarred individuals, affecting manufacturers, importers, distributors, retailers, consumers, and federal enforcement agencies without creating new spending programs.